# ASCENDIS PHARMA A/S (ASND) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 04351P101
Page URL: https://superinvestorclub.com/stock/ASND
Last updated: 2026-07-08T13:34:37.451Z

## Summary

As of the most recent 13F filing period, ASCENDIS PHARMA A/S (ASND) is held by 1 tracked superinvestors with an aggregate position value of $414,459 representing 01812 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Polen Capital](https://superinvestorclub.com/manager/271) | Polen Capital Management | 1812 | $414,459 | 0.00% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-09-30: 1 holders, $39.6M aggregate, 0265040 shares
- 2024-12-31: 1 holders, $36,488 aggregate, 0265040 shares
- 2025-03-31: 1 holders, $24,738 aggregate, 0158720 shares
- 2025-06-30: 1 holders, $469,299 aggregate, 02719 shares
- 2025-09-30: 1 holders, $549,908 aggregate, 02766 shares
- 2025-12-31: 1 holders, $258,234 aggregate, 01211 shares
- 2026-03-31: 1 holders, $414,459 aggregate, 01812 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "ASCENDIS PHARMA A/S (ASND) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/ASND), aggregating SEC 13F, Form 4, and congressional disclosures."